share_log

Societal CDMO Announces Proposed Concurrent Public Offerings Of Common Stock And Preferred Stock; No Terms Disclosed

Benzinga Real-time News ·  Dec 12, 2022 06:46

Societal CDMO, Inc. ((", Societal", , NASDAQ:SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that it is offering to sell, subject to market and other conditions, shares of its common stock and shares of its Series A convertible preferred stock in two concurrent but separate underwritten public offerings. The offerings are being made by means of separate preliminary prospectus supplements and are not contingent upon each other. The offerings are subject to market and other conditions, and there can be no assurance as to whether or when the offerings may be completed or as to the actual size or terms of the offerings.

RBC Capital Markets is acting as sole book-running manager for the offerings.

Societal intends to use the net proceeds from the proposed offerings for the repayment of its outstanding debt facility with Athyrium and associated costs to satisfy closing conditions for a capital structure refinancing, including a sale-leaseback transaction in connection with its facility in Gainesville, Georgia and a new 3-year Term A Loan debt facility with Royal Bank of Canada. Societal intends to use the net proceeds from the proposed offerings, together with proceeds from the new Term A Loan and the sale-leaseback transaction, to repay in full and retire the outstanding debt facility with Athyrium, with any remaining proceeds to be used for general corporate and working capital purposes.

The securities are being offered by Societal pursuant to a shelf registration statement that was filed with the Securities and Exchange Commission ("SEC") on February 26, 2021, and declared effective by the SEC on April 20, 2021. The offerings of securities will be made only by means of the prospectuses and prospectus supplements that form a part of the registration statement. Preliminary prospectus supplements relating to, and describing the terms of, each offering will be filed with the SEC and will be available on the SEC's web site at www.sec.gov.

Copies of the preliminary prospectus supplements and the accompanying prospectuses relating to the securities being offered can be obtained from RBC Capital Markets, LLC, Attention: Equity Capital Markets, 200 Vesey Street, 8th Floor, New York, NY 10281, via telephone at (877) 822-4089 or via email at equityprospectus@rbccm.com. The final terms of the offerings will be disclosed in final prospectus supplements to be filed with the SEC.

This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment